Reported Earnings • Aug 05
First quarter 2027 earnings released: EPS: ₹0.88 (vs ₹0.96 in 1Q 2026) First quarter 2027 results: EPS: ₹0.88 (down from ₹0.96 in 1Q 2026). Revenue: ₹2.99b (up 18% from 1Q 2026). Net income: ₹398.1m (down 8.7% from 1Q 2026). Profit margin: 13% (down from 17% in 1Q 2026). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 6% per year and the company’s share price has also increased by 6% per year. 공고 • Jul 25
Grauer & Weil (India) Limited to Report Q1, 2027 Results on Aug 04, 2026 Grauer & Weil (India) Limited announced that they will report Q1, 2027 results on Aug 04, 2026 공고 • May 28
Grauer & Weil (India) Limited announces Annual dividend, payable on October 16, 2026 Grauer & Weil (India) Limited announced Annual dividend of INR 0.5000 per share payable on October 16, 2026, ex-date on September 09, 2026 and record date on September 09, 2026. Reported Earnings • May 27
Full year 2026 earnings released: EPS: ₹3.62 (vs ₹3.47 in FY 2025) Full year 2026 results: EPS: ₹3.62 (up from ₹3.47 in FY 2025). Revenue: ₹12.4b (up 9.3% from FY 2025). Net income: ₹1.64b (up 4.3% from FY 2025). Profit margin: 13% (in line with FY 2025). Over the last 3 years on average, earnings per share has increased by 8% per year whereas the company’s share price has increased by 11% per year. 공고 • May 26
Grauer & Weil (India) Limited, Annual General Meeting, Sep 16, 2026 Grauer & Weil (India) Limited, Annual General Meeting, Sep 16, 2026. Valuation Update With 7 Day Price Move • May 26
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹75.02, the stock trades at a trailing P/E ratio of 24.3x. Average trailing P/E is 22x in the Chemicals industry in India. Total returns to shareholders of 45% over the past three years. 공고 • Oct 17
Grauer & Weil (India) Limited to Report Q2, 2025 Results on Oct 24, 2024 Grauer & Weil (India) Limited announced that they will report Q2, 2025 results on Oct 24, 2024 공고 • Aug 13
Grauer & Weil (India) Limited, Annual General Meeting, Sep 25, 2024 Grauer & Weil (India) Limited, Annual General Meeting, Sep 25, 2024. 공고 • Aug 05
Grauer & Weil (India) Limited to Report Q1, 2025 Results on Aug 12, 2024 Grauer & Weil (India) Limited announced that they will report Q1, 2025 results on Aug 12, 2024 공고 • May 30
Grauer & Weil (India) Limited Recommends Dividend for the Financial Year 2023-24 Grauer & Weil (India) Limited at its board meeting held on May 28, 2024, the Board of Directors, subject to approvals of the Shareholders at the upcoming Annual General Meeting, has recommended the payments of Dividend @ 50%, that is INR 0.50 per equity share of INR 1 each for the Financial Year 2023-24, to all those Shareholders whose names appears on the Record Date, for Dividend purposes. 공고 • May 23
Grauer & Weil (India) Limited to Report Q4, 2024 Results on May 28, 2024 Grauer & Weil (India) Limited announced that they will report Q4, 2024 results on May 28, 2024 공고 • Nov 04
Grauer & Weil (India) Limited to Report Q2, 2024 Results on Nov 09, 2023 Grauer & Weil (India) Limited announced that they will report Q2, 2024 results at 3:30 PM, Indian Standard Time on Nov 09, 2023 Valuation Update With 7 Day Price Move • Aug 18
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₹133, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 26x in the Chemicals industry in India. Total returns to shareholders of 103% over the past year. 공고 • Aug 01
Grauer & Weil (India) Limited to Report Q1, 2024 Results on Aug 10, 2023 Grauer & Weil (India) Limited announced that they will report Q1, 2024 results at 3:30 PM, Indian Standard Time on Aug 10, 2023 Upcoming Dividend • Jul 28
Upcoming dividend of ₹0.80 per share at 0.7% yield Eligible shareholders must have bought the stock before 04 August 2023. Payment date: 09 September 2023. Payout ratio is a comfortable 16% and this is well supported by cash flows. Trailing yield: 0.7%. Lower than top quartile of Indian dividend payers (1.5%). Lower than average of industry peers (0.9%). Reported Earnings • Jul 21
Full year 2023 earnings released: EPS: ₹4.98 (vs ₹3.48 in FY 2022) Full year 2023 results: EPS: ₹4.98 (up from ₹3.48 in FY 2022). Revenue: ₹9.83b (up 28% from FY 2022). Net income: ₹1.13b (up 43% from FY 2022). Profit margin: 12% (up from 10% in FY 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 17% p.a. on average during the next 2 years, compared to a 10.0% growth forecast for the Chemicals industry in India. Reported Earnings • May 30
Full year 2023 earnings released: EPS: ₹4.98 (vs ₹3.48 in FY 2022) Full year 2023 results: EPS: ₹4.98 (up from ₹3.48 in FY 2022). Revenue: ₹10.0b (up 30% from FY 2022). Net income: ₹1.13b (up 43% from FY 2022). Profit margin: 11% (up from 10% in FY 2022). The increase in margin was driven by higher revenue. Reported Earnings • Feb 12
Third quarter 2023 earnings released: EPS: ₹1.52 (vs ₹1.03 in 3Q 2022) Third quarter 2023 results: EPS: ₹1.52 (up from ₹1.03 in 3Q 2022). Revenue: ₹2.51b (up 24% from 3Q 2022). Net income: ₹344.4m (up 48% from 3Q 2022). Profit margin: 14% (up from 12% in 3Q 2022). The increase in margin was driven by higher revenue. Recent Insider Transactions • Dec 20
Non-Executive Independent Director recently sold ₹5.9m worth of stock On the 16th of December, Suresh Pareek sold around 64k shares on-market at roughly ₹92.22 per share. This transaction amounted to 4.4% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger sale worth ₹14m. Insiders have been net sellers, collectively disposing of ₹37m more than they bought in the last 12 months. Recent Insider Transactions • Dec 01
Non-Executive Independent Director recently sold ₹14m worth of stock On the 29th of November, Suresh Pareek sold around 137k shares on-market at roughly ₹100 per share. This transaction amounted to 8.7% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of ₹31m more than they bought in the last 12 months. Recent Insider Transactions • Nov 18
Insider recently sold ₹6.4m worth of stock On the 15th of November, Veena Pareek sold around 65k shares on-market at roughly ₹98.35 per share. This transaction amounted to 52% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of ₹15m more than they bought in the last 12 months. Valuation Update With 7 Day Price Move • Oct 07
Investor sentiment improved over the past week After last week's 15% share price gain to ₹77.30, the stock trades at a trailing P/E ratio of 21.1x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 18% over the past year. Recent Insider Transactions • Oct 01
Insider recently sold ₹4.2m worth of stock On the 29th of September, Veena Pareek sold around 63k shares on-market at roughly ₹67.68 per share. This transaction amounted to 23% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of ₹8.3m more than they bought in the last 12 months. Recent Insider Transactions • Sep 16
Insider recently sold ₹218k worth of stock On the 13th of September, Vinod Haritwal sold around 3k shares on-market at roughly ₹72.50 per share. This transaction amounted to 49% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of ₹568k more than they bought in the last 12 months. Upcoming Dividend • Sep 07
Upcoming dividend of ₹0.65 per share Eligible shareholders must have bought the stock before 14 September 2022. Payment date: 22 October 2022. Payout ratio is a comfortable 19% and this is well supported by cash flows. Trailing yield: 0.9%. Lower than top quartile of Indian dividend payers (1.6%). Higher than average of industry peers (0.7%). Reported Earnings • Sep 01
Full year 2022 earnings released: EPS: ₹3.47 (vs ₹3.04 in FY 2021) Full year 2022 results: EPS: ₹3.47 (up from ₹3.04 in FY 2021). Revenue: ₹7.68b (up 27% from FY 2021). Net income: ₹787.6m (up 14% from FY 2021). Profit margin: 10% (down from 11% in FY 2021). The decrease in margin was driven by higher expenses. Board Change • Aug 25
Less than half of directors are independent Following the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 5 non-independent directors. Additional Non-Executive Independent Director Ayush Agarwala was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Board Change • Aug 25
Less than half of directors are independent Following the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 5 non-independent directors. Additional Non-Executive Independent Director Ayush Agarwala was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Recent Insider Transactions • Jun 07
Insider recently sold ₹350k worth of stock On the 2nd of June, Vinod Haritwal sold around 5k shares on-market at roughly ₹70.00 per share. This was the largest sale by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months. Reported Earnings • Jun 02
Full year 2022 earnings released: EPS: ₹3.47 (vs ₹3.04 in FY 2021) Full year 2022 results: EPS: ₹3.47 (up from ₹3.04 in FY 2021). Revenue: ₹7.82b (up 29% from FY 2021). Net income: ₹787.6m (up 14% from FY 2021). Profit margin: 10% (down from 11% in FY 2021). The decrease in margin was driven by higher expenses. Valuation Update With 7 Day Price Move • May 19
Investor sentiment improved over the past week After last week's 15% share price gain to ₹72.50, the stock trades at a trailing P/E ratio of 18x. Average trailing P/E is 18x in the Chemicals industry in India. Board Change • Apr 27
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Non-Executive Independent Director Prerna Goradia was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Board Change • Mar 07
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Non-Executive Independent Director Prerna Goradia was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Valuation Update With 7 Day Price Move • Jan 04
Investor sentiment improved over the past week After last week's 17% share price gain to ₹66.55, the stock trades at a trailing P/E ratio of 15.4x. Average trailing P/E is 19x in the Chemicals industry in India. Reported Earnings • Aug 18
First quarter 2022 earnings released: EPS ₹0.86 (vs ₹0.05 in 1Q 2021) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2022 results: Revenue: ₹1.35b (up 113% from 1Q 2021). Net income: ₹195.0m (up ₹183.9m from 1Q 2021). Profit margin: 14% (up from 1.8% in 1Q 2021). The increase in margin was driven by higher revenue.